Polygenic Risk Driven Pragmatic Statin Trial for Heart Disease Prevention

NCT06820086 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

2714

Enrollment

OTHER

Sponsor class

Conditions

PRS-based Primary Prevention of CVD

Interventions

DRUG: Rosuvastatin 20mg

Sponsor

Mikk JÜRISSON

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]